EQS-News

First Berlin expands operations to the Gulf region with new regional headquarters in Riyadh 12.11.2025, 09:00 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: First Berlin Capital GmbH / Key word(s): Expansion
First Berlin expands operations to the Gulf region with new regional headquarters in Riyadh

12.11.2025 / 09:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Press Release

First Berlin expands operations to the Gulf region with new regional headquarters in Riyadh
 

The move marks First Berlin’s first international expansion, positioning Riyadh as its gateway to the Gulf and a bridge for innovation between Europe and Saudi Arabia’s fast-growing life-sciences sector.

Berlin, Germany / Riyadh, Saudi Arabia – 12 November 2025 – First Berlin, an international corporate-finance and investment boutique focused on small- and mid-cap companies, has today officially opened its new offices in Riyadh, Saudi Arabia.

The new entity, First Berlin GCC, will serve as the Berlin-based boutique’s regional headquarters in the Gulf Cooperation Council (GCC). The decision to establish its first international office in Riyadh underscores the city’s rise as the region’s most dynamic hub for biotechnology, healthcare innovation, and investment; it reflects the growing synergy between the European and Saudi economies under the Kingdom’s Vision 2030 transformation agenda.

“Riyadh today represents a confident, forward-looking market that is redefining what innovation means in the region,” said Martin Bailey, Founder and Managing Partner of First Berlin. “What drew us here is the combination of strategic vision, institutional maturity, and the scale of opportunity. For a firm that grew out of Germany’s own culture of research and entrepreneurship, Riyadh feels like a place where ideas can quickly turn into impact. This is about partnership and knowledge exchange, not just presence.”

Through its Riyadh office, First Berlin GCC will connect European biotech innovators and investors with Saudi institutions, including the Health Sector Transformation Program, the Research, Development and Innovation Authority (RDIA), and the National Biotechnology Strategy. The goal is to accelerate knowledge transfer, localise biomanufacturing, and help build a globally competitive regional Saudi bioeconomy.

“Saudi Arabia is not just attracting innovation; it’s shaping it,” says Dr. Tameem Ashry, Head of First Berlin GCC. “From biotechnology to precision medicine, the Kingdom is redefining what regional leadership in life sciences looks like. Our role is to create bridges between Saudi talent and global markets, between research and capital, between ideas and implementation.”

Dr. Ashry, a graduate of King Saud University and Harvard Medical School, was a Misk Fellow in 2021, part of Saudi Arabia’s flagship leadership program nurturing global innovators. He brings a track record spanning academia, consulting, and biotech entrepreneurship, including contributions to the Saudi National Biotechnology Strategy and a partnership role at a Saudi biotech firm.

First Berlin’s expansion represents more than a new chapter for the company; it highlights how European expertise and Saudi ambition can converge to drive regional healthcare transformation. By embedding itself in Riyadh’s growing innovation ecosystem, the firm aims to contribute to Vision 2030’s goals of building a knowledge-based, locally anchored economy driven by data, research, and advanced manufacturing.

About First Berlin

Founded in 1998, First Berlin is an independent corporate-finance and investment boutique headquartered in Berlin. The firm advises small- and mid-cap companies on capital increases, IPOs, bond placements, and M&A transactions, with strong sector expertise in life sciences, biopharma, infrastructure, and renewable energy.

With offices in Berlin and Riyadh, First Berlin GCC bridges European capital with Middle Eastern innovation; offering clients global reach with local insight. https://firstberlin.com

Media Contact GCC

Dr. Tameem Ashry
First Berlin GCC
Phone: +966 55 413 3001
Email: t.ashry@firstberlin.com

International Media Contact (MC Services)

Raimund Gabriel
Phone: +49 89 210 228 32
Email: firstberlin@mc-services.eu



12.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2228166  12.11.2025 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Handeln Sie Aktien bei SMARTBROKER+ für 0 Euro!* Profitieren Sie von kostenloser Depotführung, Zugriff auf 29 deutsche und internationale Börsenplätze und unschlagbar günstigen Konditionen – alles in einer innovativen, brandneuen App. Jetzt zu SMARTBROKER+ wechseln und durchstarten!

*Ab 500 EUR Ordervolumen über gettex. Zzgl. marktüblicher Spreads und Zuwendungen.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

7:05 Uhr • Artikel • BörsenNEWS.de

Gestern 23:02 Uhr • Artikel • dpa

Gestern 22:46 Uhr • Artikel • dpa

Gestern 22:40 Uhr • Artikel • dpa-AFX

Gestern 22:32 Uhr • Artikel • dpa-AFX

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer